BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
BIOGEN INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 29, 2026
$233.48+0.83 (+0.36%)
Close on Oct 19, 2026
- Market cap
- $34.65B
- P/E (TTM)
- 25.1
- Dividend yield
- –
Charting library not installed
Copy the licensed TradingView charting_library folder to apps/web/public/charting_library/, or set TV_LIBRARY_PATH, then reload. Setup steps are in docs/ADVANCED-CHARTS.md.